The new analysis showed why women struggling to fully recover from COVID-19 may benefit from a targeted rehab program. 

The agency said a final decision will be made by April 2022. 

Researchers wrote that they hope their findings can help guide the creation of policies that reduce disparities in care for AFib patients. 

The new analysis, published in the Journal of the American Heart Association, explored what happens with AFib patients shift their anticoagulant strategy. 

All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.

Researchers took a fresh look at data from the EMPEROR-Preserved trial, sharing their findings in Circulation.

The analysis included data from more than 85,000 breast cancer patients and an equal number of healthy women with no history of breast cancer. 

Patient outcomes didn't change much when an additional operator was involved—but could this approach impact care in other ways? 

Potential medical applications include brains inside heads and hearts within chests.